IBDEI1F8 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22988,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22988,1,3,0)
 ;;=3^Hepatitis C w/o Hepatic Coma,Acute
 ;;^UTILITY(U,$J,358.3,22988,1,4,0)
 ;;=4^B17.10
 ;;^UTILITY(U,$J,358.3,22988,2)
 ;;=^5000542
 ;;^UTILITY(U,$J,358.3,22989,0)
 ;;=B18.2^^78^994^3
 ;;^UTILITY(U,$J,358.3,22989,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22989,1,3,0)
 ;;=3^Hepatitis C,Chr
 ;;^UTILITY(U,$J,358.3,22989,1,4,0)
 ;;=4^B18.2
 ;;^UTILITY(U,$J,358.3,22989,2)
 ;;=^5000548
 ;;^UTILITY(U,$J,358.3,22990,0)
 ;;=B35.6^^78^994^4
 ;;^UTILITY(U,$J,358.3,22990,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22990,1,3,0)
 ;;=3^Tinea Cruris
 ;;^UTILITY(U,$J,358.3,22990,1,4,0)
 ;;=4^B35.6
 ;;^UTILITY(U,$J,358.3,22990,2)
 ;;=^119711
 ;;^UTILITY(U,$J,358.3,22991,0)
 ;;=B35.3^^78^994^5
 ;;^UTILITY(U,$J,358.3,22991,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22991,1,3,0)
 ;;=3^Tinea Pedis
 ;;^UTILITY(U,$J,358.3,22991,1,4,0)
 ;;=4^B35.3
 ;;^UTILITY(U,$J,358.3,22991,2)
 ;;=^119732
 ;;^UTILITY(U,$J,358.3,22992,0)
 ;;=B97.89^^78^994^6
 ;;^UTILITY(U,$J,358.3,22992,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22992,1,3,0)
 ;;=3^Viral Agents as the Cause of Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,22992,1,4,0)
 ;;=4^B97.89
 ;;^UTILITY(U,$J,358.3,22992,2)
 ;;=^5000879
 ;;^UTILITY(U,$J,358.3,22993,0)
 ;;=B02.9^^78^994^7
 ;;^UTILITY(U,$J,358.3,22993,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22993,1,3,0)
 ;;=3^Zoster w/o Complications
 ;;^UTILITY(U,$J,358.3,22993,1,4,0)
 ;;=4^B02.9
 ;;^UTILITY(U,$J,358.3,22993,2)
 ;;=^5000501
 ;;^UTILITY(U,$J,358.3,22994,0)
 ;;=C44.91^^78^995^1
 ;;^UTILITY(U,$J,358.3,22994,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22994,1,3,0)
 ;;=3^Basal cell carcinoma of skin, unspecified
 ;;^UTILITY(U,$J,358.3,22994,1,4,0)
 ;;=4^C44.91
 ;;^UTILITY(U,$J,358.3,22994,2)
 ;;=^5001092
 ;;^UTILITY(U,$J,358.3,22995,0)
 ;;=D17.9^^78^995^2
 ;;^UTILITY(U,$J,358.3,22995,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22995,1,3,0)
 ;;=3^Benign lipomatous neoplasm, unspecified
 ;;^UTILITY(U,$J,358.3,22995,1,4,0)
 ;;=4^D17.9
 ;;^UTILITY(U,$J,358.3,22995,2)
 ;;=^5002020
 ;;^UTILITY(U,$J,358.3,22996,0)
 ;;=C67.9^^78^995^3
 ;;^UTILITY(U,$J,358.3,22996,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22996,1,3,0)
 ;;=3^Malignant neoplasm of bladder, unspecified
 ;;^UTILITY(U,$J,358.3,22996,1,4,0)
 ;;=4^C67.9
 ;;^UTILITY(U,$J,358.3,22996,2)
 ;;=^5001263
 ;;^UTILITY(U,$J,358.3,22997,0)
 ;;=C18.9^^78^995^4
 ;;^UTILITY(U,$J,358.3,22997,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22997,1,3,0)
 ;;=3^Malignant neoplasm of colon, unspecified
 ;;^UTILITY(U,$J,358.3,22997,1,4,0)
 ;;=4^C18.9
 ;;^UTILITY(U,$J,358.3,22997,2)
 ;;=^5000929
 ;;^UTILITY(U,$J,358.3,22998,0)
 ;;=C15.9^^78^995^5
 ;;^UTILITY(U,$J,358.3,22998,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22998,1,3,0)
 ;;=3^Malignant neoplasm of esophagus, unspecified
 ;;^UTILITY(U,$J,358.3,22998,1,4,0)
 ;;=4^C15.9
 ;;^UTILITY(U,$J,358.3,22998,2)
 ;;=^5000919
 ;;^UTILITY(U,$J,358.3,22999,0)
 ;;=C32.9^^78^995^6
 ;;^UTILITY(U,$J,358.3,22999,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22999,1,3,0)
 ;;=3^Malignant neoplasm of larynx, unspecified
 ;;^UTILITY(U,$J,358.3,22999,1,4,0)
 ;;=4^C32.9
 ;;^UTILITY(U,$J,358.3,22999,2)
 ;;=^5000956
 ;;^UTILITY(U,$J,358.3,23000,0)
 ;;=C34.92^^78^995^7
 ;;^UTILITY(U,$J,358.3,23000,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23000,1,3,0)
 ;;=3^Malignant neoplasm of left bronchus/lung,unspec part
